News Releases

<< Back
Prestige Brands Holdings, Inc. Reports Fiscal First Quarter 2011
Results

IRVINGTON, N.Y., Aug 05, 2010 (BUSINESS WIRE) --

Prestige Brands Holdings, Inc. (NYSE:PBH) today announced results for the first quarter of fiscal 2011, which ended on June 30, 2010.

Net income from continuing operations for the first quarter was $9.6 million, or $0.19 of fully diluted earnings per share, 20% higher than the prior year's comparable period's net income of $8.0 million or $0.16 per fully diluted share.

Total revenues for the quarter ended June 30, 2010 were $73.4 million, 3% higher than the prior year comparable quarter's results of $71.0 million.

Operating income for the first fiscal quarter was $21.3 million, 15% higher than the prior year's comparable period results of $18.5 million. The increase in operating income was due to an increase in gross profit resulting from higher revenues combined with favorable advertising and promotion (A&P) and general and administrative (G&A) expenditures.

Commentary

"This quarter's results affirm the strength of our core OTC business model and the overall direction of our strategic plan," said Matthew Mannelly, President and CEO. "We are pleased with the growth of our core OTC brands as well as their long-term potential. We remain confident in achieving our long-term goals, however, we are realistic about the overall economic environment and the challenges we face for the full year. In particular, given last years' heavy retailer buy-in of cough/cold products in anticipation of H1N1, the second quarter will be challenging from a revenue standpoint. Retailers have told us as well as our competitors that this buy-in will not be repeated this year in the second quarter."

Mr. Mannelly concluded, "We continue to look at optimizing our growth portfolio as a marathon, not a sprint. With our refinancing in place, we are focused on both organic growth in our core OTC brands as well as pursuing appropriate outside OTC opportunities."

Results by Segment for the First Fiscal Quarter

Over-the-Counter Healthcare Products (OTC)

Net revenues of $44.3 million for the OTC segment were $4.0 million or 10% higher than the prior year comparable period results of $40.3 million. The increase was driven by sales of Clear Eyes(R), Compound W(R), Wartner(R), New Skin(R), Murine Tears, Percogesic(R), and Sleep-Eze(R) in Canada, partially offset by decreases on the Allergen Block products and Earigate(R).

Of the Company's six core brands, five are in the OTC segment. These include Chloraseptic(R), Clear Eyes(R), Compound W(R), Little Remedies(R), and The Doctor's(R) NightGuard(R). Revenues for our core OTC brands were up 16% in the aggregate over the prior year comparable quarter.

Household Products

Revenues for this segment were $26.5 million, 3% less than the comparable first quarter of fiscal 2010. A sales increase on the Spic and Span(R) brand was offset by declines on the Comet(R) and Chore Boy(R) brands.

Personal Care Products

Revenues for this segment were $2.6 million, 22% below the prior year comparable quarter's revenues of $3.3 million. The sales decline traces to distribution losses for the Cutex(R) brand in the fall of 2010.

Free Cash Flow

Free cash flow is a "non-GAAP" measure as that term is defined by the Securities and Exchange Commission in Regulation G. Free cash flow is presented here because management believes it is a commonly used measure of liquidity, and is an indication of cash available for debt repayment and acquisitions. The Company defines free cash flow as operating cash flows less capital expenditures.

The Company's free cash flow for the first quarter ended June 30, 2010 was $20.6 million, composed of operating cash flow of $20.7 million, less capital expenditures of $0.1 million. This is a $2.6 million increase over the comparable quarter's free cash flow of $18.0 million, composed of operating cash flow of $18.1 million, less capital expenditures of $0.1 million.

Conference Call

The Company will host a conference call today at 8:30 a.m. EDT. To access the call, listeners calling from within North America may dial 800-299-0433 at least 15 minutes prior to the start of the call. To access the call from outside North America, callers should dial 617-801-9712. The conference passcode is "prestige". The Company will provide a live internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrandsinc.com. Telephonic replays will be available for two weeks following the completion of the call and can be accessed at 888-286-8010 within North America, and at 617-801-6888 from outside North America. The passcode is 79554986.

About Prestige Brands Holdings, Inc.

Located in Irvington, New York, Prestige Brands Holdings, Inc. is a marketer and distributor of brand name over-the-counter healthcare, household and personal care products sold throughout the U.S., Canada and certain international markets. Key brands include Compound W(R) wart remover, Chloraseptic(R) sore throat and allergy treatment, New-Skin(R) liquid bandage, Clear Eyes(R) and Murine(R) eye and ear care products, The Doctor's(R) NightGuard(R) dental protector, Little Remedies(R) pediatric over-the-counter products, Cutex(R) nail polish remover, Comet(R) and Spic and Span(R) household products, and other well-known brands.

Forward-Looking Statements

Note: This news release contains "forward-looking statements" within the meaning of the federal securities laws and that are intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe, "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the Company's future performance, liquidity, and borrowing capacity of Prestige Brands Holdings. These statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those expected as a result of a variety of factors. A discussion of factors that could cause results to vary is included in the Company's Annual Report on Form 10-K and other periodic and other reports filed with the Securities and Exchange Commission.

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

(Unaudited)

Three Months Ended June 30
(In thousands, except share data) 2010 2009
Revenues
Net sales $ 72,706 $ 70,395
Other revenues 719 617
Total revenues 73,425 71,012
Cost of Sales
Cost of sales (exclusive of depreciation shown below) 34,546 33,181
Gross profit

38,879

37,831
Operating Expenses
Advertising and promotion 7,598 8,765
General and administrative 7,414 8,195
Depreciation and amortization 2,547 2,345
Total operating expenses 17,559 19,305
Operating income 21,320 18,526
Other expense
Interest expense 5,461 5,654
Loss on extinguishment of debt 300 --
Total other expense 5,761 5,654
Income from continuing operations before income taxes 15,559 12,872
Provision for income taxes 5,944 4,878
Income from continuing operations 9,615 7,994
Discontinued Operations
Income (loss) from discontinued operations, net of income tax (10 ) 331
Net income $ 9,605 $ 8,325
Basic earnings per share:
Income from continuing operations $ 0.19 $ 0.16
Net income $ 0.19 $ 0.17
Diluted earnings per share:
Income from continuing operations $ 0.19 $ 0.16
Net income $ 0.19 $ 0.17
Weighted average shares outstanding:
Basic 50,038 49,982
Diluted 50,105 50,095

Prestige Brands Holdings, Inc.

Consolidated Balance Sheets

(Unaudited)

(In thousands) June 30, March 31,
Assets 2010 2010
Current assets
Cash and cash equivalents $ 33,106 $ 41,097
Accounts receivable 28,543 30,621
Inventories 28,076 29,162
Deferred income tax assets 6,745 6,353
Prepaid expenses and other current assets 2,888 4,917
Total current assets 99,358 112,150
Property and equipment 1,243 1,396
Goodwill 111,489 111,489
Intangible assets 556,840 559,229
Other long-term assets 6,705 7,148
Total Assets $ 775,635 $ 791,412
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable $ 12,112 $ 12,771
Accrued interest payable 3,443 1,561
Other accrued liabilities 10,161 11,733
Current portion of long-term debt 1,500 29,587
Total current liabilities 27,216 55,652
Long-term debt
Principal amount 298,125 298,500
Less unamortized discount (3,801 ) (3,943 )
Long-term debt, net of unamortized discount 294,324 294,557
Deferred income tax liabilities 114,574 112,144
Total Liabilities 436,114 462,353
Stockholders' Equity
Preferred stock - $0.01 par value
Authorized - 5,000 shares
Issued and outstanding - None -- --
Common stock - $0.01 par value
Authorized - 250,000 shares
Issued - 50,173 shares at June 30, 2010 and 50,154 shares at March 31, 2010 502 502
Additional paid-in capital 384,884 384,027
Treasury stock, at cost -- 124 shares at June 30, 2010 and March 31, 2010 (63 ) (63 )
Accumulated other comprehensive income (loss) -- --
Retained earnings (accumulated deficit) (45,802 ) (55,407 )
Total Stockholders' Equity 339,521 329,059
Total Liabilities and Stockholders' Equity $ 775,635 $ 791,412

Prestige Brands Holdings, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

Three Months Ended June 30
(In thousands) 2010 2009
Operating Activities
Net income $ 9,605 $ 8,325
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 2,547 2,777
Deferred income taxes 2,036 2,430
Amortization of deferred financing costs 397 480
Impairment of goodwill and intangible assets
Stock-based compensation cost 857 671
Loss on extinguishment of debt 300 --
Loss on disposition of equipment 126 --
Changes in operating assets and liabilities
Accounts receivable 2,078 3,010
Inventories 1,086 528
Prepaid expenses and other current assets 2,029 (1,452 )
Accounts payable (659 ) 584
Income taxes payable -- 1,551
Accrued liabilities 310 (836 )
Net cash provided by operating activities 20,712 18,068
Investing Activities
Purchases of equipment (130 ) (98 )
Net cash provided by (used for) investing activities (130 ) (98 )
Financing Activities
Proceeds from the issuance of debt -- --
Payment of deferred financing costs (111 ) --
Repayment of long-term debt (28,462 ) (17,000 )
Purchase of common stock for treasury -- --
Net cash used for financing activities (28,573 ) (17,000 )
Increase (decrease) in cash (7,991 ) 970
Cash - beginning of period 41,097 35,181
Cash - end of period $ 33,106 $ 36,151
Interest paid $ 3,182 $ 8,085
Income taxes paid $ 342 $ 1,100

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

Business Segments

(Unaudited)

For the Three Months Ended June 30, 2010

Over-the-
Counter
Healthcare

Household
Cleaning

Personal Care Consolidated
(In thousands)
Net sales $ 44,323 $ 25,814 $ 2,569 $ 72,706
Other revenues 14 701 4 719
Total revenues 44,337 26,515 2,573 73,425
Cost of sales 15,582 17,412 1,552 34,546
Gross profit 28,755 9,103 1,021 38,879
Advertising and promotion 5,154 2,324 120 7,598
Contribution margin $ 23,601 $ 6,779 $ 901 31,281
Other operating expenses 9,961
Operating income 21,320
Other expense 5,761
Provision for income taxes 5,944
Income from continuing operations 9,615
Loss from discontinued operations, net of income benefit (10 )
Net income $ 9,605

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

Business Segments

(Unaudited)

For the Three Months Ended June 30, 2009

Over-the-
Counter
Healthcare

Household
Cleaning

Personal Care Consolidated
(In thousands)
Net sales $ 40,272 $ 26,841 $ 3,282 $ 70,395
Other revenues 11 606 -- 617
Total revenues 40,283 27,447 3,282 71,012
Cost of sales 13,528 17,801 1,852 33,181
Gross profit 26,755 9,646 1,430 37,831
Advertising and promotion 6,740 1,919 106 8,765
Contribution margin $ 20,015 $ 7,727 $ 1,324 29,066
Other operating expenses 10,540
Operating income 18,526
Other expense 5,654
Provision for income taxes 4,878
Income from continuing operations 7,994
Income from discontinued operations, net of income tax 331
Net income $ 8,325

SOURCE: Prestige Brands Holdings, Inc.

Prestige Brands Holdings, Inc.
Dean Siegal, 914-524-6819

Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

AST
6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449
help@astfinancial.com
https://www.astfinancial.com

Subscribe

Stay up to date with investor news, stock information and SEC filings.
Subscribe »